Wednesday, April 24, 2019

Africa launched World’s first malaria vaccine in Geneva

Africa launched World’s first malaria vaccine in Geneva
Africa launched World’s first malaria vaccine in Geneva

Malawi is the world's first malaria vaccine trials every year after 435,000 people worldwide have been accused worldwide for over 30 years, has been initiated to prevent deadly disease for children. The World Health Organization (WHO) welcomed the Malawi government's historic program. RTS, first and only known as malaria vaccine S, Malawi in Africa will make it the first of three countries where it will be available to children for 2 years. In the coming weeks, the Wana and Kenya vaccine will be implemented. , WHO said in a statement. Malaria is one of the leading killers in the world, which claims the life of children at every two minutes.

In a statement, WHO said Ghana and Kenya 
vaccines will be screened in the coming weeks. Every two minutes. Most of these deaths occur in Africa, and 250,000 children die each year. Malaria is one of the leading killers in the world, which claims the life of children at WHO estimates 89 percent of India's malaria cases are in Southeast Asia. The National Vector Barn Disease Control Program (NVBDCP), the country's 1.090.724 malaria in 2016 and 331 killed in the country. Ghana, Kenya and Malawi Health and Piattiac Ministry, a nonprofit organization and GlaxoSmithKline, Vaccine Developer and WHO Coordinated Pilot Program manufacturer is working on a co-operation with health issues including 10 million vaccination doses donated for this pilot.

President Piattiac says CEO Steve Davis, 
"We are grateful to WHO and Malawi salaries this historic milestone with his leadership," and we look forward to introduction of the Ghana vaccine at the end of this year. Malaria vaccine is one of the innovations needed to eliminate this disease, and we are moving towards a malaria-free world with all the nations and our many partners. " The goal of the malaria vaccine pilot is to add about 360,000 children per year in three countries. The health ministry determines where the vaccine is given; They focus on high levels of malaria radiation, where the vaccine is highly effective.

"The first malaria vaccine in the world 
will be helping the world the most stressed challenge to reduce the health burden." This novel device is the result of the latest vaccine science applied staff to contribute to the fight against GSK colleagues and malaria collaborations, "said vaccines GSK Chief Medical Officer Dr Thomas Brier. "We look forward to the safety of the WHO and the PATH, and, in the parallel, continuous global health future vaccine effect we have seen in the pilot results."

Share This
Previous Post
Next Post

Pellentesque vitae lectus in mauris sollicitudin ornare sit amet eget ligula. Donec pharetra, arcu eu consectetur semper, est nulla sodales risus, vel efficitur orci justo quis tellus. Phasellus sit amet est pharetra